Linked Life Data

16453263

Source:http://linkedlifedata.com/resource/pubmed/id/16453263

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16453263rdf:typepubmed:Citationlld:pubmed
pubmed-article:16453263lifeskim:mentionsumls-concept:C0015859lld:lifeskim
pubmed-article:16453263lifeskim:mentionsumls-concept:C0085393lld:lifeskim
pubmed-article:16453263lifeskim:mentionsumls-concept:C0021403lld:lifeskim
pubmed-article:16453263lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:16453263lifeskim:mentionsumls-concept:C0872192lld:lifeskim
pubmed-article:16453263lifeskim:mentionsumls-concept:C1548795lld:lifeskim
pubmed-article:16453263pubmed:issue5lld:pubmed
pubmed-article:16453263pubmed:dateCreated2006-2-2lld:pubmed
pubmed-article:16453263pubmed:abstractTextPatients undergoing chemotherapy for cancer are highly susceptible to influenza virus infection. Prevention of influenza virus infection is complicated in the immunocompromised host because of suboptimal responses to the trivalent inactivated influenza vaccine (TIV). A new, live attenuated influenza vaccine (LAIV; FluMist) may offer a more effective alternative to TIV, but the safety of this LAIV in immunocompromised patients must first be established. In the present study, FluMist was administered to ferrets immunocompromised by treatment with dexamethasone and cytarabine. Ferrets exhibited no signs or symptoms attributable to FluMist, and nasal clearance of LAIV strains from immunocompromised ferrets was similar to that from control ferrets. Serum antibody responses against the vaccinating strains were analyzed as a measure of vaccine efficacy. Antibody titers to all 3 vaccine strains in immunocompromised ferrets were similar to those seen in mock-treated control ferrets, as assessed by microneutralization assay. These findings support the potential use of this vaccine in immunocompromised humans.lld:pubmed
pubmed-article:16453263pubmed:languageenglld:pubmed
pubmed-article:16453263pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16453263pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16453263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16453263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16453263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16453263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16453263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16453263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16453263pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16453263pubmed:statusMEDLINElld:pubmed
pubmed-article:16453263pubmed:monthMarlld:pubmed
pubmed-article:16453263pubmed:issn0022-1899lld:pubmed
pubmed-article:16453263pubmed:authorpubmed-author:McCullersJona...lld:pubmed
pubmed-article:16453263pubmed:authorpubmed-author:HuberVictor...lld:pubmed
pubmed-article:16453263pubmed:issnTypePrintlld:pubmed
pubmed-article:16453263pubmed:day1lld:pubmed
pubmed-article:16453263pubmed:volume193lld:pubmed
pubmed-article:16453263pubmed:ownerNLMlld:pubmed
pubmed-article:16453263pubmed:authorsCompleteYlld:pubmed
pubmed-article:16453263pubmed:pagination677-84lld:pubmed
pubmed-article:16453263pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:meshHeadingpubmed-meshheading:16453263...lld:pubmed
pubmed-article:16453263pubmed:year2006lld:pubmed
pubmed-article:16453263pubmed:articleTitleLive attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets.lld:pubmed
pubmed-article:16453263pubmed:affiliationDepartment of Infectious Disease, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA.lld:pubmed
pubmed-article:16453263pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16453263pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16453263lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16453263lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16453263lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16453263lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16453263lld:pubmed